Harmony Biosciences To Participate In Two Investor Conferences In November
11/11/2021 - 08:05 AM
PLYMOUTH MEETING, Pa. , Nov. 11, 2021 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases, today announced that Harmony's President and CEO, John C. Jacobs , will participate in fireside chats and host investor meetings at the following upcoming virtual conferences:
Jefferies London Healthcare Conference Fireside Chat: A pre-recorded fireside chat will be available on-demand beginning on Thursday, November 18 at 8:00am GMT / 3:00am ET through Friday, November 19 at 5:00pm GMT / 12:00pm ET 1x1 Meetings: Thursday, November 18, 2021 and Friday, November 19, 2021 Piper Sandler 33rd Annual Virtual Healthcare Conference Fireside Chat: A pre-recorded fireside chat will be available on-demand beginning on Monday, November 22 nd at 10:00am ET 1x1 Meetings: Tuesday, November 30, 2021 The audio webcast of the fireside chats will be available on the investor page of Harmony's website at https://ir.harmonybiosciences.com/ .
About Harmony Biosciences Plymouth Meeting, PA. The Company was established by Paragon Biosciences, LLC, and is focused on providing novel treatment options for people living with rare neurological diseases who have unmet medical needs. For more information on Harmony, please visit the company's website: www.harmonybiosciences.com .
Harmony Biosciences Investor Contact: Patti Bank ir@harmonybiosciences.com
Harmony Biosciences Media Contact: nleone@harmonybiosciences.com
https://www.prnewswire.com/news-releases/harmony-biosciences-to-participate-in-two-investor-conferences-in-november-301421739.html
SOURCE Harmony Biosciences
Harmony Biosciences Holdings Inc
HRMY Rankings
#4980 Ranked by Stock Gains
HRMY Stock Data
Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Tags
Health Technology, Pharmaceuticals: Major, Manufacturing, Medicinal and Botanical Manufacturing
About HRMY
patients are at the beginning, middle, and heart of all we do. harmony biosciences, llc, is a privately-owned biopharmaceutical company. the company was established in october 2017 with a vision to provide novel treatment options for people living with rare and orphan diseases with an emphasis on central nervous system disorders, starting with a focus on helping patients who live with narcolepsy. harmony biosciences is committed to advancing the understanding of narcolepsy and providing information and resources to individuals who live with, and healthcare professionals who treat, patients with narcolepsy.
